Welcome to our dedicated page for AdvanSix SEC filings (Ticker: ASIX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AdvanSix Inc. filings document an integrated chemistry issuer with common stock traded on the NYSE under ASIX. Its 8-K reports furnish operating results for Nylon Solutions, Plant Nutrients and Chemical Intermediates, cash dividends on common stock, executive and director appointments, committee assignments, and amendments to its senior secured revolving credit facility.
Proxy materials disclose board composition, independence, committee structure, executive compensation, equity awards and shareholder voting matters. The filing record also covers capital structure, financial obligations and governance practices tied to AdvanSix's vertically integrated manufacturing assets, raw-material exposure, plant operations and end markets for nylon, fertilizers and chemical intermediates.
Victory Capital Management filed a Schedule 13G/A reporting beneficial ownership of 2,178,472 AdvanSix (ASIX) common shares, representing 8.12% as of 09/30/2025. The firm reports sole voting power over 2,155,884 shares and sole dispositive power over 2,178,472 shares, with no shared voting or dispositive power. The filing is made in the ordinary course by an investment adviser and states the holdings were not acquired to change or influence control.
AdvanSix Inc. amended its senior secured revolving credit facility, extending the maturity of revolving credit commitments held by participating lenders in an aggregate principal amount of $452 million to the earlier of October 27, 2027 or termination of the commitments under the agreement. The total facility size remains $500 million.
The remaining $48 million of revolving credit commitments that were not extended will continue to mature on the earlier of October 27, 2026 or termination of the commitments. The amendment also includes conforming changes consistent with the extension terms.
The filing shows that Achilles B. Kintiroglou, SVP and General Counsel of AdvanSix Inc. (ASIX), sold 577 shares of the company's common stock on 10/03/2025 at a reported price of $20 per share, reducing his direct beneficial ownership to 30,265 shares. The sale was executed under a pre-existing Rule 10b5-1 trading plan adopted on 11/12/2024, and is reported on a Form 4 signed by the reporting person on 10/03/2025. No derivative transactions are reported and no other changes to ownership are disclosed.
AdvanSix Inc. insider filing reports a proposed sale of 577 shares of Common Stock through Merrill Lynch on or about 10/03/2025 with an aggregate market value of $11,540.00. The shares were acquired and paid for on 02/28/2025 as the vesting of a restricted stock unit award. The filer also disclosed two recent sales: 571 shares on 09/02/2025 and 571 shares on 08/01/2025, showing recent periodic dispositions by the same person. The filing states the seller represents they do not possess undisclosed material adverse information about the issuer.
Patrick Williams, a director of AdvanSix Inc. (ASIX), received an allocation of 677 deferred stock units on 09/30/2025 at an indicated price of $19.38 per share under the company’s deferred compensation plan. Each unit represents the economic equivalent of one share and will be paid out in shares upon distribution. After the allocation, Mr. Williams is reported to beneficially own 34,965 shares, which includes 95 additional shares credited as dividend equivalents related to unvested restricted stock units and deferred stock units acquired in transactions exempt from Rule 16a-11. The Form 4 was signed on 10/01/2025.
AdvanSix Inc. (ASIX) director Donald P. Newman reported a transaction dated 09/30/2025 allocating 1,418 deferred stock units to his deferred stock unit fund under the AdvanSix Deferred Compensation Plan at an indicated value of $19.38 per unit. Each deferred stock unit represents the economic equivalent of one share and will be paid out in shares upon distribution. After this allocation, Mr. Newman beneficially owns 13,497 shares/units, which includes an additional 53 shares credited as dividend equivalents tied to unvested restricted stock units and deferred stock units acquired in transactions exempt from Rule 16a-11. The Form 4 was signed on behalf of Mr. Newman on 10/01/2025.
AdvanSix Inc. (ASIX) Form 3 filing: Daryl Roberts, identified as a Director, filed an initial Section 16 statement reporting zero shares of AdvanSix common stock beneficially owned. The event date triggering the filing is 09/02/2025 and the filing was signed on 09/08/2025 by Achilles B. Kintiroglou on behalf of the reporting person. No derivative holdings or indirect ownership are disclosed.
AdvanSix Inc. (ASIX) Form 3 reports that Dana C. O'Brien, listed at the provided address, is a director of the issuer and filed an initial Section 16 statement. The filing shows zero shares of common stock beneficially owned, and the form is signed on behalf of the reporting person. This is a routine initial ownership disclosure with no recorded beneficial ownership reported.
AdvanSix Inc. (ASIX) insider sale reported on Form 4. Achilles B. Kintiroglou, SVP and General Counsel, sold 571 shares of AdvanSix common stock on 09/02/2025 at $21.20 per share. After the sale, the reporting person beneficially owned 30,842 shares. The filing notes the sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on 11/12/2024, and the Form 4 was signed on 09/03/2025. The disclosure shows a routine, pre-arranged disposition by an officer with a clear compliance disclosure.
Notice of proposed sale under Rule 144: This Form 144 indicates that Achilles Kintiroglou intends to sell 571 shares of AdvanSix Inc. common stock through Merrill Lynch (NYC) with an aggregate market value of $12,105.20, with an approximate sale date of 09/02/2025. The shares were acquired on 02/28/2025 through the vesting of a restricted stock unit award granted under the issuer's equity compensation plan. The filing also reports three prior sales in the past three months of 571 shares each on 06/02/2025, 07/02/2025, and 08/01/2025, with gross proceeds of $13,504.15, $14,189.35, and $11,522.78 respectively. The filer attests not to possess undisclosed material adverse information.